(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) jumping 15.14% to €5.78 on Wednesday while BEL 20 jumped 0.9% to €3,631.05.
NYXOAH’s last close was €5.02, 45.79% under its 52-week high of €9.26.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.76%.
Volatility
NYXOAH’s last week, last month’s, and last quarter’s current intraday variation average was 7.19%, 0.76%, and 2.66%.
NYXOAH’s highest amplitude of average volatility was 7.58% (last week), 3.08% (last month), and 2.66% (last quarter).
Yearly Top and Bottom Value
NYXOAH’s stock is valued at €5.78 at 21:35 EST, way under its 52-week high of €9.26 and way above its 52-week low of €3.79.
More news about NYXOAH (NYXH.BR).
